Clinical trial
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
NCT01342367
Study timeline
Study start (actual)2010-12-17Date precision: day
Registry last updated2025-06-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
BicalutamideDRUG · verified · RxNorm: bicalutamide
DutasterideDRUG · verified · RxNorm: dutasteride
FinasterideDRUG · verified · RxNorm: finasteride
RadiationRADIATION
Sponsors & collaborators
University of Chicagolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01342367 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.